Zoetis Inc. Share Price

Equities

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse 21:00:08 17/05/2024 BST 5-day change 1st Jan Change
174 USD +0.18% Intraday chart for Zoetis Inc. +2.95% -11.83%
Sales 2024 * 9.15B 720B Sales 2025 * 9.77B 769B Capitalization 79.42B 6,251B
Net income 2024 * 2.51B 198B Net income 2025 * 2.76B 217B EV / Sales 2024 * 9.15 x
Net Debt 2024 * 4.31B 339B Net Debt 2025 * 3.75B 295B EV / Sales 2025 * 8.52 x
P/E ratio 2024 *
31.8 x
P/E ratio 2025 *
28.8 x
Employees 14,100
Yield 2024 *
0.99%
Yield 2025 *
1.13%
Free-Float 90.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.18%
1 week+2.95%
Current month+9.28%
1 month+18.79%
3 months-7.63%
6 months-0.44%
Current year-11.83%
More quotes
1 week
168.63
Extreme 168.63
174.99
1 month
144.80
Extreme 144.8
174.99
Current year
144.80
Extreme 144.8
200.53
1 year
144.80
Extreme 144.8
201.92
3 years
124.15
Extreme 124.1483
249.27
5 years
90.14
Extreme 90.14
249.27
10 years
30.24
Extreme 30.24
249.27
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 31/12/11
Director of Finance/CFO 52 31/05/21
Chief Tech/Sci/R&D Officer - 31/12/10
Members of the board TitleAgeSince
Chairman 71 31/12/12
Director/Board Member 73 31/07/13
Director/Board Member 74 31/05/13
More insiders
Date Price Change Volume
17/05/24 174.1 +0.20% 1,999,468
16/05/24 173.7 +0.25% 1,695,019
15/05/24 173.3 +2.61% 2,585,818
14/05/24 168.9 +0.57% 2,050,060
13/05/24 167.9 -0.67% 2,125,792

Delayed Quote Nyse, May 17, 2024 at 09:00 pm

More quotes
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
174.1 USD
Average target price
211.2 USD
Spread / Average Target
+21.34%
Consensus